HUMAN COXSACKIEVIRUS B4
UNII FYF75V7FDY

Substance Identification & Data

This profile provides standardized clinical and technical data for Human Coxsackievirus B4, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FYF75V7FDY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) 1427210. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FYF75V7FDY
CAS Registry Number
N/A
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
HUMAN COXSACKIEVIRUS B4
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
FYF75V7FDY
The specific atomic composition represented as a molecular structure string.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
NCBI Taxonomy
138949
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Human Coxsackievirus B4. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ENTEROVIRUS HUMAN ENTEROVIRUS B SEROGROUP COXSACKIEVIRUS SEROTYPE B4
HUMAN COXSACKIEVIRUS B4
HUMAN ENTEROVIRUS B COXSACKIEVIRUS B4
HUMAN ENTEROVIRUS B SEROGROUP COXSACKIEVIRUS SEROTYPE B4

NDC Products Containing HUMAN COXSACKIEVIRUS B4

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: